- Report
- November 2024
- 93 Pages
Global
From €3500EUR$4,294USD£3,136GBP
- Report
- January 2024
- 81 Pages
Global
From €3500EUR$4,294USD£3,136GBP
- Report
- November 2025
- 108 Pages
Brazil, China, India, ... Brazil, China, India, Russia
From €5234EUR$5,995USD£4,532GBP
- Report
- September 2025
- 37 Pages
Brazil
From €4361EUR$4,995USD£3,776GBP
- Report
- September 2025
- 37 Pages
Mexico
From €4361EUR$4,995USD£3,776GBP
- Report
- September 2025
- 38 Pages
Japan
From €4361EUR$4,995USD£3,776GBP
- Report
- September 2025
- 38 Pages
China
From €4361EUR$4,995USD£3,776GBP
- Report
- September 2025
- 37 Pages
South Korea
From €4361EUR$4,995USD£3,776GBP
- Report
- September 2025
- 37 Pages
Russia
From €4361EUR$4,995USD£3,776GBP
- Report
- September 2025
- 38 Pages
Spain
From €4361EUR$4,995USD£3,776GBP
- Report
- September 2025
- 37 Pages
Italy
From €4361EUR$4,995USD£3,776GBP
- Report
- September 2025
- 39 Pages
United Kingdom
From €4361EUR$4,995USD£3,776GBP
- Report
- September 2024
- 99 Pages
China
From €1572EUR$1,800USD£1,361GBP
- Report
- September 2024
- 232 Pages
China
From €3493EUR$4,000USD£3,024GBP

The Cardiac Assist Devices market is a subset of the Cardiovascular Devices market, which includes a range of products used to diagnose, treat, and monitor cardiovascular diseases. Cardiac Assist Devices are used to support or replace the function of the heart, and can be used for both short-term and long-term support. These devices are typically used in patients with severe heart failure, and can be used to bridge the gap between heart failure and transplantation. Common types of Cardiac Assist Devices include ventricular assist devices, intra-aortic balloon pumps, and total artificial hearts.
Some of the major companies in the Cardiac Assist Devices market include Abiomed, Medtronic, Berlin Heart, SynCardia Systems, and ReliantHeart. Show Less Read more